Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Dec;113(12):1669-74.
doi: 10.1289/ehp.7917.

A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs

Affiliations
Review

A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs

Fernando Barbosa Jr et al. Environ Health Perspect. 2005 Dec.

Abstract

Lead concentration in whole blood (BPb) is the primary biomarker used to monitor exposure to this metallic element. The U.S. Centers for Disease Control and Prevention and the World Health Organization define a BPb of 10 microg/dL (0.48 micromol/L) as the threshold of concern in young children. However, recent studies have reported the possibility of adverse health effects, including intellectual impairment in young children, at BPb levels < 10 microg/dL, suggesting that there is no safe level of exposure. It appears impossible to differentiate between low-level chronic Pb exposure and a high-level short Pb exposure based on a single BPb measurement; therefore, serial BPb measurements offer a better estimation of possible health outcomes. The difficulty in assessing the exact nature of Pb exposure is dependent not so much on problems with current analytical methodologies, but rather on the complex toxicokinetics of Pb within various body compartments (i.e., cycling of Pb between bone, blood, and soft tissues). If we are to differentiate more effectively between Pb stored in the body for years and Pb from recent exposure, information on other biomarkers of exposure may be needed. None of the current biomarkers of internal Pb dose have yet been accepted by the scientific community as a reliable substitute for a BPb measurement. This review focuses on the limitations of biomarkers of Pb exposure and the need to improve the accuracy of their measurement. We present here only the traditional analytical protocols in current use, and we attempt to assess the influence of confounding variables on BPb levels. Finally, we discuss the interpretation of BPb data with respect to both external and endogenous Pb exposure, past or recent exposure, as well as the significance of Pb determinations in human specimens including hair, nails, saliva, bone, blood (plasma, whole blood), urine, feces, and exfoliated teeth.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ATSDR 1999. Toxicological Profile for Lead. Atlanta, GA:Agency for Toxic Substances and Disease Registry. - PubMed
    1. ATSDR 2001. Hair Analysis Panel Discussion: Exploring the State of the Science. Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: http://www.atsdr.cdc.gov/HAC/hair_analysis/ [accessed 15 April 2005].
    1. Ambrose TM, Al-Lozi M, Scott MG. Bone lead concentrations assessed by in vivo X-ray fluorescence. Clin Chem. 2000;46:1171–1178. - PubMed
    1. Barry PS. Concentrations of lead in the tissues of children. 1981. Br J Ind Med. 1981;38:61–71. - PMC - PubMed
    1. Brito JAA, McNeill FE, Webber CE, Chettle DR. Grid search: an innovative method for the estimation of the rates of lead exchange between body compartments. J Environ Monit. 2005;7:241–247. - PubMed

LinkOut - more resources

-